Stay updated on Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.
Latest updates to the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.5%
- Check12 days agoChange DetectedThe website has added several new dates for 2024 and 2025, along with an update to version v2.11.0, while removing previous notices and dates, including the prior version v2.10.5.SummaryDifference2%
- Check19 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.7%
- Check27 days agoChange DetectedDifference0.4%
- Check34 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.5%
- Check41 days agoChange DetectedDifference0.4%
Stay in the know with updates to Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.